BioSpace News Archive

Kalorama said that the global contract in vitro diagnostic (IVD) manufacturing segment is valued at more than 12 billion dollars and has nearly 500 competitors.

Initiative Raises $25,000 for Lung Cancer Research.

Wize Pharma, Inc. (OTCQB: WIZP) (OTCQB: WIZPD), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed enrolment of all 62 patients in its multi-center Phase II clinical trial in Israel of LO2A for the treatment of patients with moderate to severe Conjunctivochalasis (CCH).

New Data Opens Door to Addressing Multi-Billion Dollar Autoimmune Market

Relay Therapeutics, a biotech company dedicated to developing breakthrough medicines by leveraging insights from protein motion, today announced the appointments of Don Bergstrom, M.D., Ph.D. as Executive Vice President, Head of Research and Development, Brian Adams as General Counsel, and Tom Catinazzo as Vice President of Finance.

Combined entity enables providers, patients and families to improve digital engagement

Hospital system aligns with 154 physicians and providers

Industry Veteran Tim Ingram and Engineering and Marketing Specialist Dennis Taylor Add Operational Strength

Appointed Iqbal Husain, Ph.D., as its Senior Vice President, Program Management, and Michael Zdanowski as its Vice President, Biopharmaceutical Operations.

Q-State Biosciences, Inc. today announced that the company has entered into a strategic collaboration with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to discover drugs using Q-State’s novel Optopatch™ platform.